BlueStem Wealth Partners’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.1M Sell
765,762
-96,522
-11% -$4.09M 3.3% 10
2026
Q1
$33.6M Sell
862,284
-484,681
-36% -$19.7M 3.74% 7
2025
Q4
$55M Buy
1,346,965
+631,523
+88% +$25.7M 6.07% 4
2025
Q3
$28.9M Sell
715,442
-347,497
-33% -$13.4M 3.31% 7
2025
Q2
$39.1M Sell
1,062,939
-516,918
-33% -$17.5M 4.8% 6
2025
Q1
$52.5M Buy
1,579,857
+382,928
+32% +$13.3M 7.15% 3
2024
Q4
$41.4M Buy
+1,196,929
New +$42M 5.44% 6

Other funds holding RECS

BlueStem Wealth Partners's RECS Position: Q2 2026 in Review

BlueStem Wealth Partners reduced its Columbia Research Enhanced Core ETF (RECS) stake by 11% in Q2 2026, selling an estimated $4.09M and leaving 765,762 shares worth $33.1M. The position accounts for 3.3% of the portfolio, ranked #10.

BlueStem Wealth Partners first reported a position in RECS in Q4 2024 and has held it in 7 quarters since. The position peaked at $55M in Q4 2025. 186 funds tracked by Wall St. Rank hold RECS as of Q2 2026.

  • BlueStem Wealth Partners held 765,762 shares of Columbia Research Enhanced Core ETF worth $33.1M as of Q2 2026.
  • BlueStem Wealth Partners sold 96,522 Columbia Research Enhanced Core ETF shares in Q2 2026, an estimated $4.09M.
  • Columbia Research Enhanced Core ETF made up 3.3% of BlueStem Wealth Partners's portfolio in Q2 2026, its #10 holding.
  • BlueStem Wealth Partners first reported a position in Columbia Research Enhanced Core ETF in Q4 2024 and has held it in 7 quarters since.
  • BlueStem Wealth Partners's Columbia Research Enhanced Core ETF position peaked at $55M in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q2 2026.

Based on BlueStem Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.